| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/24/2013 | WO2011156007A9 Rt-lamp assay for the detection of pan-serotype dengue virus |
| 01/24/2013 | US20130024961 Methods of Modulating Thrombocytopenia and Modified Transgenic Pigs |
| 01/24/2013 | US20130023565 Influenza a 2009 pandemic h1n1 polypeptide fragments comprising endonuclease activity and their use |
| 01/24/2013 | US20130023481 Adenovirus E1A Fragments for Use in Anti-Cancer Therapies |
| 01/24/2013 | US20130023474 Compositions, uses and methods for treatment of metabolic disorders and diseases |
| 01/24/2013 | US20130023473 Methods and pharmaceutical composition for the preservation of vascular endothelial cell barrier integrity |
| 01/24/2013 | US20130023472 Ldl quantitation and method of use |
| 01/24/2013 | US20130023442 Single nucleotide polymorphism for predicting recurrence of hepatocellular carcinoma |
| 01/24/2013 | US20130023441 Identification of Tumors |
| 01/24/2013 | US20130023440 Polynucleotides Associated With Age-Related Macular Degeneration and Methods for Evaluating Patient Risk |
| 01/24/2013 | US20130023439 Method and Kit for Determining Sensitivity to Decitabine Treatment |
| 01/24/2013 | US20130023433 Methods of detecting nucleic acid sequences with high specificity |
| 01/24/2013 | US20130023431 Methods of Assessing Chromosomal Instabilities |
| 01/24/2013 | US20130023430 Cancer stem cell gene variants are associated with tumor recurrence |
| 01/24/2013 | US20130023429 Transcription chip |
| 01/24/2013 | US20130023427 Methods for assessing genomic instabilities in tumors |
| 01/24/2013 | US20130023426 Methods of Detecting Signatures of Disease or Conditions in Bodily Fluids |
| 01/24/2013 | US20130023425 Detecting pax2 for the diagnosis of breast cancer |
| 01/24/2013 | US20130023424 Detecting pax2 for the diagnosis of breast cancer |
| 01/24/2013 | US20130023421 Protein display |
| 01/24/2013 | US20130023041 Method and Apparatus for Holding Cells |
| 01/24/2013 | US20130023006 Analyzer, method for measuring a sample, and non-transitory machine-readable storage medium |
| 01/24/2013 | US20130023003 Kit including substrates with various surface chemistries |
| 01/24/2013 | US20130023002 Use of a substrate in a method for measuring the activity of available proteolytic enzymes |
| 01/24/2013 | US20130023001 Use of a substrate in a method for measuring the activity of proteolytic enzymes |
| 01/24/2013 | US20130023000 Devices and Formulations for Detecting, Screening and Monitoring Levels of Certain Constituents in Bodily Fluids and Method |
| 01/24/2013 | US20130022999 Protein fragment complementation assays for the detection of biological or drug interactions |
| 01/24/2013 | US20130022996 Genetically modified mice and engraftment |
| 01/24/2013 | US20130022990 Cellular labeling for nuclear magnetic resonance techniques |
| 01/24/2013 | US20130022989 Dental stem cell reprogramming |
| 01/24/2013 | US20130022988 Yeast cells expressing amyloid beta and uses therefor |
| 01/24/2013 | US20130022987 Method for Diagnosing or Determining the Prognosis of Colorectal Cancer (CRC) Using Novel Autoantigens: Gene Expression Guided Autoantigen Discovery |
| 01/24/2013 | US20130022986 Method for manufacturing pancreatic-hormone-producing cells |
| 01/24/2013 | US20130022985 Examination method to determine contraction or activity of diseases related immune system or joint system |
| 01/24/2013 | US20130022984 Method for the non-specific enrichment of microorganisms |
| 01/24/2013 | US20130022983 Colon and Rectal Tumor Markers and Methods of Use Thereof |
| 01/24/2013 | US20130022982 Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury |
| 01/24/2013 | US20130022981 Novel human lysosomal protein and methods of its use |
| 01/24/2013 | US20130022980 Rna- and dna-copying enzymes |
| 01/24/2013 | US20130022979 3.4kb MITOCHONDRIAL DNA DELETION FOR USE IN THE DETECTION OF CANCER |
| 01/24/2013 | US20130022978 Measurement of Brain CDP-Diacylglycerol Synthase 1 Enzyme and Uses Thereof |
| 01/24/2013 | US20130022977 Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities |
| 01/24/2013 | US20130022976 Hyperthermostable endonuclease iv substrate probe |
| 01/24/2013 | US20130022975 Method for detecting arteriosclerotic diseases on the basis of single nucleotide polymorphism at human chromosome 5p15.3 |
| 01/24/2013 | US20130022974 Dna methylation profiles in cancer |
| 01/24/2013 | US20130022973 Multiplex Amplification for the Detection of Nucleic Acid Variations |
| 01/24/2013 | US20130022972 Oligonucleotides and methods for detecting lavender foal syndrome |
| 01/24/2013 | US20130022971 Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy |
| 01/24/2013 | US20130022970 Methods Of Classifying Biological Samples For Predicting Response To Tyrosine Kinase Inhibitor Treatment |
| 01/24/2013 | US20130022969 Single-pad strip for an improved lateral flow assay and a test device using the same |
| 01/24/2013 | US20130022967 NUCLEIC ACID MOLECULE HAVING AFFINITY TO RODENT-DERIVED IgG ANTIBODY, BINDER, DETECTION REAGENT, AND DETECTION KIT |
| 01/24/2013 | US20130022966 Methods of Treating Cancer Using Notch Pathway Inhibitors |
| 01/24/2013 | US20130022965 Test system for visual analysis |
| 01/24/2013 | US20130022964 Use of Ribozymes in the Detection of Adventitious Agents |
| 01/24/2013 | US20130022963 Direct amplification and detection of viral and bacterial pathogens |
| 01/24/2013 | US20130022962 Method and apparatus for diagnostic analyses |
| 01/24/2013 | US20130022961 Assay for jc virus antibodies |
| 01/24/2013 | US20130022960 Rapid test for detecting infection |
| 01/24/2013 | US20130022667 Fidgetin-like 2 as a target to enhance wound healing |
| 01/24/2013 | US20130022664 E.coli lpfa antigen for prevention and treatment of infectious diseases |
| 01/24/2013 | US20130022620 Assays and methods pertaining to pre-amyloid intermediates |
| 01/24/2013 | US20130022617 Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis |
| 01/24/2013 | US20130022611 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 01/24/2013 | US20130022596 Methods and compositions for diagnostic use in cancer patients |
| 01/24/2013 | US20130022593 Methods of diagnosing endometriosis |
| 01/24/2013 | US20130022586 Production and use of bacterial histamine |
| 01/24/2013 | US20130022583 Direct Conversion of Cells to Cells of Other Lineages |
| 01/24/2013 | US20130022582 Multipotent nestin-positive cells |
| 01/24/2013 | US20130022549 Halogenated phenols for diagnostics, antioxidant protection and drug delivery |
| 01/24/2013 | US20130022547 Attenuated mycoplasma gallisepticum strains |
| 01/24/2013 | US20130022363 Photosensor and image forming device incorporating the same |
| 01/24/2013 | DE19945553B4 Verfahren zum Nachweis von mindestens einer multiresistenten Keimart, insbesondere MRSA- und VRE-Keimen Method for the detection of at least one multi-resistant germ, especially MRSA and VRE germs |
| 01/24/2013 | DE102012014339A1 Verwendung eines Substrats in einem Verfahren zur Messung der Aktivität von vorhandenen proteolytischen Enzymen Use of a substrate in a process for measuring the activity of proteolytic enzymes existing |
| 01/24/2013 | DE102012014337A1 Verwendung eines Substrats in einem Verfahren zur Messung der Aktivität von proteolytischen Enzymen Use of a substrate in a process for measuring the activity of proteolytic enzymes |
| 01/24/2013 | DE102011108254A1 Diagnosing malignant diseases, preferably cancer, comprises providing sample obtained from bodily fluid or bodily waste, and determining concentration of microRNA including microRNA-1246 and microRNA-1290 in the sample |
| 01/24/2013 | CA2842103A1 Embodiments of a probe and method for targeting nucleic acids |
| 01/24/2013 | CA2842068A1 Isolated brachyspira and methods and compositions for expanding and isolating brachyspira |
| 01/24/2013 | CA2842023A1 Cell culture apparatus, apparatus for long-term observation of cell culture, method for long-term cell culture, and method for long-term observation of cell culture |
| 01/24/2013 | CA2841710A1 Methods of transcription activator like effector assembly |
| 01/24/2013 | CA2841531A1 Compositions and method for detecting human parvovirus nucleic acid and for detecting hepatitis a virus nucleic acids in single-plex or multiplex assays |
| 01/24/2013 | CA2841060A1 Method and kit for dna typing of hla gene |
| 01/24/2013 | CA2837981A1 Rapid and accurate analysis of protein sialylation |
| 01/23/2013 | EP2549399A1 Assessment of Wnt pathway activity using probabilistic modeling of target gene expression |
| 01/23/2013 | EP2549260A1 Method and system for analyzing a liquid cell sample by turbimetry and digital holographic microscopy |
| 01/23/2013 | EP2548972A1 Methods for the diagnosis of fetal abnormalities |
| 01/23/2013 | EP2548971A1 CHAC1 transcript variants as marker for breast cancer |
| 01/23/2013 | EP2548970A1 Method for the early diagnosis of clinically latent placental insufficiency in placental dysmaturity |
| 01/23/2013 | EP2548969A1 Screening method for candidate agonist compounds for adiponectin receptor 1 |
| 01/23/2013 | EP2548961A1 Method for determination of progression risk of glaucoma |
| 01/23/2013 | EP2548888A1 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same |
| 01/23/2013 | EP2548886A1 Genetic test for genetic disposition of haemophilia A in Havanese dogs |
| 01/23/2013 | EP2548647A1 Assay devices and methods for the detection of analytes |
| 01/23/2013 | EP2548580A1 Pharmaceutical for pseudo-exercise therapy |
| 01/23/2013 | EP2548029A1 Methods for predicting cardiovascular events and monitoring treatment using pcsk9 |
| 01/23/2013 | EP2548022A2 Multiphase microarrays and uses thereof |
| 01/23/2013 | EP2548021A2 Method for determining substance non-toxicity |
| 01/23/2013 | EP2547809A1 Methods, probe sets, and kits for detection of deletion of tumor suppressor genes by fluorescence in situ hybridization |
| 01/23/2013 | EP2547795A2 Compositions and methods for the detection of genomic features |
| 01/23/2013 | EP2547794A2 Salivary bioassay for early detection of bone loss |
| 01/23/2013 | EP2547793A1 Identification of a genetic risk factor for diabetes |